Stock Events

Stock Events

Valiant 

CHF176.8
41
+CHF3.2+1.84% Tuesday 15:30

Statistics

Day High
176.8
Day Low
175.8
52W High
176.8
52W Low
108
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
3.39%
Dividend
6

Upcoming

18
MAY
Dividend Ex
Increased
 
20
MAY
Dividend Payment
Increased
 
18
MAY 27
Dividend Ex
Estimated
 
20
MAY 27
Dividend Payment
Estimated
 
18
MAY 28
Dividend Ex
Estimated
 

Dividends

3.39%Dividend Yield
May 25
CHF5.8
May 24
CHF5.5
May 23
CHF5
May 22
CHF5
May 21
CHF5
10Y Growth
5.24%
5Y Growth
3.71%
3Y Growth
6.27%
1Y Growth
3.45%

Earnings

25AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.01
1.05
2.09
3.13
Expected EPS
0.011576840962662401
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VATN.SW. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Valiant in various therapeutic areas, including infectious diseases and oncology.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in similar sectors as Valiant, offering a wide range of pharmaceutical products and competing in healthcare solutions.
Merck
MRK
Mkt Cap214.76B
Merck is a leading pharmaceutical company that competes with Valiant in developing medications for various diseases, including cancer and infectious diseases.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes with Valiant in the biopharmaceutical field, focusing on treatments for conditions such as rheumatoid arthritis and Crohn's disease.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Valiant in areas like oncology and neurology, offering innovative medicines.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a pharmaceutical and healthcare company that competes with Valiant in developing vaccines and medications for a variety of illnesses.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company competing with Valiant in the discovery, development, and delivery of medicines for cancer and other diseases.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global pharmaceutical company that competes with Valiant in providing healthcare solutions across a broad range of therapeutic areas.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG competes with Valiant in the pharmaceutical and diagnostics sectors, focusing on oncology, immunology, and infectious diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Valiant in developing and commercializing prescription medicines in several therapeutic areas.

About

Valiant Holding AG, together with its subsidiaries, provides various banking products and services for private retail clients, affluent private clients, self-employed individuals, and small and medium-sized companies. The company offers savings accounts; real estate financing; loans for working capital and other basic services for businesses; unsecured and consumer loans; payment transaction services through its mobile banking app; and retirement planning and investment solutions, as well as electronic banking services. It operates approximately 96 branch offices and 240 ATMs in 13 cantons in Switzerland. The company was founded in 1824 and is based in Lucerne, Switzerland.
Show more...
CEO
ISIN
CH0014786500

Listings

LSE
GB
0QPU.LSE
SW
CH
VATN.SW
F
DE
VAT.F
SZ
CN
002643.SZ

0 Comments

Share your thoughts

FAQ

What is Valiant stock price today?▼
The current price of VATN.SW is CHF176.8 CHF — it has increased by +1.84% in the past 24 hours. Watch Valiant stock price performance more closely on the chart.
What is Valiant stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Valiant stocks are traded under the ticker VATN.SW.
Is Valiant stock price growing?▼
VATN.SW stock has risen by +2.67% compared to the previous week, the month change is a +5.87% rise, over the last year Valiant has showed a +48.57% increase.
When is the next Valiant earnings date?▼
Valiant is going to release the next earnings report on April 25, 2026.
What were Valiant earnings last quarter?▼
VATN.SW earnings for the last quarter are 3.13 CHF per share, whereas the estimation was 3.01 CHF resulting in a +4.13% surprise. The estimated earnings for the next quarter are N/A CHF per share.
Does Valiant pay dividends?▼
Yes, VATN.SW dividends are paid annual. The last dividend per share was 5.8 CHF. As of today, Dividend Yield (FWD)% is 3.39%.
When did Valiant complete a stock split?▼
Valiant has not had any recent stock splits.